SUBSCRIBE
SUBSCRIBE
News   Business   Deals

MDS Inc. to Sell Central Labs to Czura Thornton for $8 Million

October 9, 2009 | 
1 min read
Bookmark and Share

Reuters -- Health sciences company MDS Inc on Friday said it agreed to sell its Central Labs operations to private investment group Czura Thornton for about $8 million.
Mergers & acquisitions
MORE ON THIS TOPIC
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
September 9, 2026
 · 
1 min read
 · 
Gabrielle Masson
Yellow road That has bright light at the destination, 3D Render.
Deals
Biotech is back, with H1 progress smoothing glide path through end of year: Truist
September 4, 2026
 · 
3 min read
 · 
Annalee Armstrong
Tension, separation, danger or risk concepts. Frayed rope is about to brake on blue background with copy space.
Antibody-drug conjugate (ADC)
Pfizer punts Seagen ADC, further muddying value of the $43B buyout
September 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Trustworthy and honesty to believe in work together, integrity or trust for partnership, support and reliable to help success together concept, businessman acrobat hold hand tight by trusted partner.
Deals
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
September 3, 2026
 · 
1 min read
 · 
Tristan Manalac